meta_analysis
2022
High Quality
Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized trials
Jibril AT, Jayedi A, Shab-Bidar S
Published in Endocrine Connections
Key Findings
Alpha-lipoic acid reduced HbA1c and fasting glucose dose-dependently, but below clinically important thresholds.
Conclusions
Effects on cardiometabolic risk factors were statistically but not clinically important.
Supplements Studied
Alpha Lipoic Acid (ALA)
Compound
Despite significant improvements, the effects of oral ALA supplementation on cardiometabolic risk factors in patients with T2D were not clinically important.
Related Health Concerns
Study Details
Year:2022
Quality Score:7/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.